The trademark application ORVEXLI was filed by Gilead Sciences Ireland UC, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on April 4, 2022, and it was registered by office on July 12, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Pharmaceutical preparations for the treatment of liver, digestive, respiratory, immunological, oncological and hematological conditions, diseases and disorders
Antiviral pharmaceutical preparations
Antifungal pharmaceutical preparations
Pharmaceutical preparations for the treatment of inflammation
Pharmaceutical preparations for the treatment and prevention of infectious diseases
Anti-fibrotic pharmaceutical preparations
Pharmaceutical preparations for the treatment of blood disorders
Pharmaceutical preparations for the treatment of hepatitis and HIV infection
Pharmaceutical preparations for the treatment of arthritis
Pharmaceutical preparations for treatment of coronavirus infection.
The mark was filed in class 44 with Information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatment, including such services provided on-line from a computer network or the Internet and providing information and advisory services regarding the diagnosis and treatment of diseases and medical disorders..